Stock Screener

Show:

Sort

Country

Sector

Risk rating

1

2

3

4

5

6

7

Risk factors

Default risk

1

2

3

4

5

6

7

Volatility

1

2

3

4

5

6

7

Stress test

1

2

3

4

5

6

7

Selling difficulty

1

2

3

4

5

6

7

Country risks

1

2

3

4

5

6

7

Other risks

1

2

3

4

5

6

7

Profitability factors

Valuation

1

2

3

4

5

6

7

Analyst view

1

2

3

4

5

6

7

Performance

1

2

3

4

5

6

7

Profitability

1

2

3

4

5

6

7

Growth

1

2

3

4

5

6

7

Dividends

1

2

3

4

5

6

7

Results: 1387

Eli Lilly and Company

UnitedHealth Group Incorporated

Johnson & Johnson

AbbVie Inc.

Merck & Co., Inc.

Thermo Fisher Scientific Inc.

Pfizer Inc.

Amgen Inc.

Abbott Laboratories

Intuitive Surgical, Inc.

Gilead Sciences, Inc.

Boston Scientific Corporation

Stryker Corporation

Danaher Corporation

CVS Health Corporation

McKesson Corporation

Hims & Hers Health, Inc.

Vertex Pharmaceuticals Incorporated

Bristol-Myers Squibb Company

Regeneron Pharmaceuticals, Inc.

HCA Healthcare, Inc.

Humana Inc.

Elevance Health, Inc.

Moderna, Inc.

The Cigna Group

Alnylam Pharmaceuticals, Inc.

Cardinal Health, Inc.

Cencora, Inc.

Agilent Technologies, Inc.

IQVIA Holdings Inc.

Insmed Incorporated

Waters Corporation

DexCom, Inc.

Zoetis Inc.

Edwards Lifesciences Corporation

Becton, Dickinson and Company

Centene Corporation

IDEXX Laboratories, Inc.

Tempus AI, Inc.

Medline Inc.

Mettler-Toledo International Inc.

ResMed Inc.

Revolution Medicines, Inc.

Penumbra, Inc.

GE HealthCare Technologies Inc.

Illumina, Inc.

Molina Healthcare, Inc.

ImmunityBio, Inc.

Natera, Inc.

Insulet Corp.

Quest Diagnostics Incorporated

Labcorp Holdings Inc.

West Pharmaceutical Services, Inc.

Biogen Inc.

Masimo Corporation

Tenet Healthcare Corporation

United Therapeutics Corporation

BridgeBio Pharma, Inc.

Zimmer Biomet Holdings, Inc.

The Cooper Companies, Inc.

Incyte Corporation

Royalty Pharma plc

Guardant Health, Inc.

STERIS plc

Hinge Health, Inc.

Ionis Pharmaceuticals, Inc.

Charles River Laboratories International, Inc.

Medpace Holdings, Inc.

Baxter International Inc.

Arrowhead Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

Align Technology, Inc.

Praxis Precision Medicines, Inc.

Neurocrine Biosciences, Inc.

Bio-Techne Corporation

Viatris Inc.

Arcellx Inc

DaVita Inc.

Bruker Corporation

RAPT Therapeutics Inc

MiniMed Group, Inc.

Halozyme Therapeutics, Inc.

Universal Health Services, Inc.

BioMarin Pharmaceutical Inc.

Encompass Health Corporation

Cytokinetics, Incorporated

Exelixis, Inc.

Elanco Animal Health Incorporated

Axsome Therapeutics, Inc.

Avantor, Inc.

Oscar Health, Inc.

Repligen Corporation

Atrium Therapeutics, Inc.

TransMedics Group, Inc.

Globus Medical, Inc.

Akero Therapeutics, Inc.

Henry Schein, Inc.

Teleflex Incorporated

Doximity, Inc.

iRhythm Holdings, Inc.

Guru Portfolios

Track the investments of top funds and market legends

Return for Q2 2026: 10.41%

Portfolio composition:

Return for Q2 2026: 6.25%

Portfolio composition: